Institutional Ownership
Ascentage Pharma Group Intl
CUSIP 04390B105SPONSORED ADSAAPGQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
7
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | 16.1K | $383.3K |
| 2 | Xy Capital Ltd | 13.0K | $310.6K |
| 3 | Tower Research Capital LLC (Trc) | 518 | $12.4K |
| 4 | Morgan Stanley | 498 | $11.9K |
| 5 | Ubs Group AG | 124 | $3.0K |
| 6 | Eversource Wealth Advisors, LLC | 24 | $573 |
| 7 | Royal Bank Of Canada | 6 | $0 |